BridgeMD
New treatment option for Analgesia
Official title Effects of Pericapsular Nerve Group Block on Postoperative Recovery for Total Hip Arthroplasty
ClinicalTrials.gov ID: NCT06183528
What this study is testing
- What it's testing
- The hypothesis of this study is that patients who undergo PENG block in before Total Hip Artroplasthy (THA) surgery with spinal anesthesia will have reduced postoperative pain scores, less need for opioid analgesics and earlier mobilisation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 85
You may be able to join if
- THA performed by posterior approach
- 40-85 age range
- ASA 1-3
You likely can't join if
- Under 40 years of age, over 85 years of age,
- ASA 4 and above,
- Cognitive impairment (Alzheimer's disease, dementia, delirium etc.),
- Hip fracture,
- Application site infection,
- Allergy to local anaesthetic agents,
See the full eligibility criteria
- THA performed by posterior approach
- 40-85 age range
- ASA 1-3
- Under 40 years of age, over 85 years of age,
- ASA 4 and above,
- Cognitive impairment (Alzheimer's disease, dementia, delirium etc.),
- Hip fracture,
- Application site infection,
- Allergy to local anaesthetic agents,
- Patients are non-consenting patients.
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Umraniye, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Umraniye, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.